Functional echocardiography: an emerging clinical tool for the neonatologist.
Martin Kluckow, Istvan Seri, Nick Evans
https://pubmed.ncbi.nlm.nih.gov/17236886Actively Recruiting
Led by Sahar Abozkaly Mahmoud · Updated on 2025-06-03
50
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying critically ill neonates who show signs of hemodynamic instability to understand their outcomes, including mortality and illness severity. The study evaluates how echocardiography (heart ultrasound) can help manage these unstable newborns by tracking the time it takes for them to become stable again. This observational study compares unstable neonates to a control group of stable neonates to assess the impact of echocardiographic assessments. Neonates in the study receive detailed clinical examinations and echocardiographic assessments using a specialized device. Based on echocardiography results, treatments such as dobutamine, volume expansion, hydrocortisone, dopamine, epinephrine, or interventions for patent ductus arteriosus (PDA) may be given according to specific heart function findings. These procedures are repeated regularly, with daily echocardiographic follow-ups to monitor heart function and stability. Participants undergo continuous monitoring including clinical exams and repeated echocardiograms to evaluate heart function parameters like ejection fraction, ductus arteriosus condition, pulmonary hypertension, and cardiac indexes. These assessments occur daily or at set intervals to track progress. The study involves neonates from birth up to 28 days old, with care and data collection continuing until discharge to measure outcomes and safety throughout hospitalization.
CONDITIONS
Impact of Echocardiography on Management of Critically Ill Neonates
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Until discharge from the NICU
Participants are regularly monitored with clinical examinations and echocardiographic assessments to detect signs of hemodynamic instability or shock.
Daily echocardiographic assessments and clinical examinations
Duration - Up to 5 days after initial echocardiographic assessment
Participants continue to undergo repeated echocardiographic assessments to evaluate cardiac function and manage conditions such as pulmonary hypertension and PDA.
Repeated echocardiographic assessments daily with an additional assessment 5 days after the first
Total: 1 location
1
Sohag University Hospital
Sohag, Egypt
Actively Recruiting
S
Sahar Abuzakaly Mahmoud, MBBS
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Martin Kluckow, Istvan Seri, Nick Evans
https://pubmed.ncbi.nlm.nih.gov/17236886S Soleymani, M Borzage, I Seri
https://pubmed.ncbi.nlm.nih.gov/20877406S M Tibby, M Hatherill, M J Marsh...
https://pubmed.ncbi.nlm.nih.gov/9496187Jonathan R Egan, Marino Festa, Andrew D Cole...
https://pubmed.ncbi.nlm.nih.gov/15711976Willem-Pieter de Boode
https://pubmed.ncbi.nlm.nih.gov/20171815Patrick J McNamara, Arvind Sehgal
https://pubmed.ncbi.nlm.nih.gov/17951547A Sehgal, P J McNamara
https://pubmed.ncbi.nlm.nih.gov/18633423